Structural modification creates safer antifungal
By manipulating the kinetics of sterol binding, an important but also highly toxic antifungal drug could become a lot safer for patients, US-based chemists report in Nature.
Want to read more?
Create a free account today!
- Gain access to all our content on chemistry, life sciences and process technology;
- Get our weekly newsletter so you never miss a story.
As a member of the KNCV, KVCV, NBV, or NVBMB you have unlimited access. Log in here.
